CelLBxHealth plc Stock OTC Markets
Stocks
ANPCF
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0199 USD | +93.20% |
|
-.--% | +18.45% |
| 07-06 | CelLBxHealth chief executive Collins to step down | AN |
| 07-06 | Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer | CI |
| Market Cap | 16.48M 22.02M 19.31M 17.83M 31.23M 2.11B 31.86M 214M 83.29M 1.03B 82.69M 80.88M 3.58B | P/E 2025 * |
-0.26x | P/E 2026 * | -0.63x |
|---|---|---|---|---|---|
| Enterprise Value | 9.18M 12.27M 10.76M 9.93M 17.4M 1.17B 17.74M 119M 46.39M 575M 46.06M 45.05M 2B | EV / Sales 2025 * |
0.89x | EV / Sales 2026 * | 0.69x |
| Free-Float |
94.31% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: CelLBxHealth plc
| 25-10-16 | Angle names Peter Collins as interim CEO | AN |
| 25-05-28 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 25-01-23 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 23-09-14 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 22-01-24 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | +93.20% | ||
| 3 months | +56.69% | ||
| 6 months | +18.45% | ||
| Current year | +18.45% |
| Current year | 0.01 |  | 0.02 |
| 1 year | 0.01 | | 0.05 |
| 3 years | 0.01 | | 0.35 |
| 5 years | 0.01 | | 1.67 |
| 10 years | 0.01 | | 1.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 1998-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2024-12-31 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 2023-05-21 |
Klaas de Boer
BRD | Director/Board Member | 61 | 2026-01-11 |
| Director/Board Member | 61 | 2026-01-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +93.20% | -.--% | - | - | 22.42M | |
| -5.12% | -3.97% | -0.86% | -28.31% | 16.54B | |
| -1.77% | +7.28% | +29.90% | +88.65% | 1.65B | |
| -0.18% | -6.16% | -44.65% | -79.94% | 1.16B | |
| -0.39% | -1.74% | -29.05% | +33.19% | 1.1B | |
| +0.29% | +0.58% | -28.86% | -54.68% | 613M | |
| -2.23% | -7.65% | -41.81% | -58.26% | 550M | |
| +0.85% | +0.94% | +27.88% | -53.49% | 449M | |
| -0.96% | +1.47% | -54.85% | -59.64% | 382M | |
| -3.37% | -3.65% | -27.79% | -27.71% | 337M | |
| Average | +8.19% | -0.43% | -18.90% | -26.69% | 2.53B | |
| Weighted average by Cap. | -3.63% | +0.39% | -4.70% | -21.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.35M 13.84M 12.14M 11.21M 19.63M 1.32B 20.02M 135M 52.34M 648M 51.96M 50.83M 2.25B | 21.65M 28.93M 25.38M 23.43M 41.04M 2.77B 41.86M 282M 109M 1.36B 109M 106M 4.71B |
| Net income | -16.35M -21.85M -19.16M -17.69M -30.99M -2.09B -31.61M -213M -82.64M -1.02B -82.05M -80.25M -3.55B | -8.55M -11.43M -10.02M -9.25M -16.21M -1.09B -16.53M -111M -43.22M -535M -42.91M -41.97M -1.86B |
| Net Debt | -7.3M -9.76M -8.56M -7.9M -13.84M -934M -14.11M -94.97M -36.9M -457M -36.64M -35.83M -1.59B | -1.6M -2.14M -1.88M -1.73M -3.03M -205M -3.09M -20.81M -8.09M -100M -8.03M -7.85M -348M |
Employees
119
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0148GBP
Average target price
0.0400GBP
Spread / Average Target
+171.19%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
- ANPCF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
